PRED-G Drug Patent Profile
✉ Email this page to a colleague
When do Pred-g patents expire, and when can generic versions of Pred-g launch?
Pred-g is a drug marketed by Allergan and is included in two NDAs.
The generic ingredient in PRED-G is gentamicin sulfate; prednisolone acetate. There are fifteen drug master file entries for this compound. Additional details are available on the gentamicin sulfate; prednisolone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRED-G?
- What are the global sales for PRED-G?
- What is Average Wholesale Price for PRED-G?
Summary for PRED-G
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PRED-G |
| What excipients (inactive ingredients) are in PRED-G? | PRED-G excipients list |
| DailyMed Link: | PRED-G at DailyMed |
US Patents and Regulatory Information for PRED-G
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | PRED-G | gentamicin sulfate; prednisolone acetate | OINTMENT;OPHTHALMIC | 050612-001 | Dec 1, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | PRED-G | gentamicin sulfate; prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 050586-001 | Jun 10, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
